Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Abroad (travel likely)Recruiting

Conditions

Lung Cancer · NSCLC · NSCLC Stage IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Kansas Cancer Center (KUCC), Fairway, Kansas, United States
Contact: Study coordinator (Clinical Trials Nurse Navigator) · ctnursenav@kumc.edu · 913-945-7552
Contact: Study coordinator (Steve Williamson, MD) · SWILLIAM@kumc.edu · 913-588-3808
The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States
Contact: Study coordinator (Clinical Trials Nurse Navigator) · ctnursenav@kumc.edu · 913-945-7552

Study leads

Jun Zhang, MD, PhD
Principal Investigator
University of Kansas Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lung Cancer Registry

Lung Cancer · NSCLC Stage IV · NSCLC, Stage III

Abroad (travel likely)Recruiting

Salzburg, Austria · Innsbruck, Austria

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Abroad (travel likely)Recruiting

Jinan, China

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Non-Small-Cell Lung Cancer (NSCLC) · Brain Metastasis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Taoyuan, Taiwan